guidelines pharmacologic therapy weight regain after bariatric surgery glp-1 Drugs vs. Pharmacotherapeutic Options for Weight Regain

Without this oversight, the process can feel confusing, and in some cases, less effective

Constructed using NotebookLM using the resources cited in the reference section

If your BMI is 40+ and you need substantial weight reduction for health reasons, the 20-25% body weight loss achievable with tirzepatide vastly exceeds the 10% typical of Qsymia

Dipeptidyl peptidase-4 inhibitors and pancreatitis risk: A meta-analysis of randomized clinical trials

Tirzepatide, marketed as Mounjaro for type 2 diabetes and Zepbound for weight management, is a dual GIP/GLP-1 receptor agonist that has transformed metabolic disease treatment

In physiological conditions, astrocytes play key housekeeping roles offering structural, metabolic, and trophic support to motor neurons [65]